Global Clinical Trial Imaging Services Market was valued at 1.3 Billion US Dollar in 2019 and expected to grow with a CAGR 5.6%. Clinical Trial imaging services are used in clinical and non-clinical trial since years. This is a set of services offered to companies such as pharmaceutical, medical device and biotechnology by contract research organization. In which many services are offered in open market such as project and data management services, image analysis, quality control and other. For instance, services such as project management has team of experts which manage workflow of a clinical trial. Additionally, these services are offered for different types of therapeutic expertise such as neurology, oncology, endocrinology, and others. Rise in adoption of imaging in clinical trials and advancements in the field of medical imaging technology are key drives of the global Clinical Trial Imaging Market. For instance, In 2020, as per Radiology Society of North America, in new development of Digital breast tomosynthesis it is found that Digital Breast Tomosynthesis Improves Invasive Cancer Detection. Analysis showed that screening with DBT improves sensitivity specificity for breast cancer and identified more invasive cancers.Despite that, challenges related to integration of imaging in clinical trials is restrain the market growth of Clinical Trial Imaging Services during forecasting years 2020-2027.
The regional analysis of the Clinical Trial Imaging Services Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. In which, North America leading the Global market of Clinical Trial Imaging Services owing to surge in use of imaging as an endpoint in clinical trials. However, APAC region holds largest market share of Clinical trial Imaging Services due to rising awareness related Imaging Clinical trial which grow the market during forecasting period 2020-2027.

Key Players in Global Clinical Trial Imaging Services Market
Biotelemetry Inc.
Biomedical Systems Corporation
Bio Clinica Inc.
Cardiovascular Imaging Technologies LLC
Icon PLC
Intrinsic Imaging LLC
Ixico PLC
Parexel International Corporation
Radiant Sage LLC
Worldcare Clinical LLC

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Software and Services:

Clinical Trial Design & Consultation Services
Reading & Analytical Services
Operational Imaging Services
Project & Data Management Services
Others
By Modality:
Magnetic Resonance Imaging
Computed Tomography
Ultrasound
Positron Emission Tomography
X-Ray
Echocardiography
Other Modalities
By End Users:
Pharmaceutical Companies
Medical Device Manufacturers
Academic and Government Research Institutes
Other End-Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy

Asia Pacific
China
India
Japan
Australia


Latin America
Brazil
Mexico
Rest of LA
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year 2017, 2018
Base year 2019
Forecast period 2020 to 2027

Target Audience of Global Clinical Trial Imaging Services Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors